Maverick Growth Partners
International Venture Capital & Private Equity
Welcome to Investor Relations at Maverick Growth Partners. We partner with visionary founders and management teams to build category-defining companies across Europe, the USA, Middle East and Asia, with a focus on healthcare innovation, longevity, and healthy nutrition.
We also focus on international property development and investing in real estate assets: health and wellness-focused residential, hospitality, and care concepts, as well as income-generating real estate with strong fundamentals and value-add potential.
Our VC & PE Venture Investment Focus
As VC and PE investor we invest in early to growth-stage companies with:
Disruptive technologies in healthcare, healthtech, bioscience, foodtech and wellness
Strong founding teams with proven execution, guts and ambition to conquer the world
Scalable business models targeting large addressable markets
Geographic emphasis: Europe (primary), USA, Middle East and Asia (emerging opportunities).
Target fund sizes: €20–100M per investment vehicle
Typical check size: €1–25M equity investments
Read also: What Are Maverick Entrepreneurs And Investors?
Our Real Estate & Wellness Infrastructure Investment Focus
Maverick Growth Partners’ prime focus as a real estate developer and investor is health and wellness-integrated real estate, combining residential living, hospitality, and care concepts with strong income generation and value-add potential. This positions our firm at the intersection of luxury real estate development and the booming longevity/wellness economy.
Wellness Real Estate
Properties that deliver superior financial returns through integrated health outcomes:
| Asset Class | Focus Areas | Key Projects | Target Returns |
|---|---|---|---|
| Assisted Lifestyle Villages | Luxury senior living with longevity clinics, preventive health, nursing home, hospice, social/recreational amenities | The Savannahs (Portugal flagship; expansion: Spain, Thailand, UAE, Cyprus, Tanzania) | 12–18% IRR + capital appreciation |
| Health & Longevity Hotels | Medical tourism resorts combining detox, multi-omics diagnostics, hyperbaric therapy, cosmetic/orthopedic procedures | Dr. Health Hotels (Algarve base + international pipeline) | 15–22% yield via occupancy + health service revenue |
| Wellness Residences | Ultra-luxury homes with private health suites, concierge medicine, community longevity programs | Almancil Senior Residences (Portugal) + UHNWI villages | Value-add: 20–30% uplift via wellness repositioning |
| Income Properties | Stabilized multifamily/office with value-add via health retrofits (e.g., metabolic health gyms, biomarker testing hubs) | Selective acquisitions across EU/Asia | 8–12% core yield + 3–5% annual growth |
Strategic Differentiators
Health Revenue Multiplier: Unlike traditional real estate, most of the properties we invest in generate recurring non-rent income from on-site clinics, longevity programs, diagnostics (€15K–150K/year per resident).
Demographic Megatrend: Aging UHNW populations seeking “longevity communities” (climate-optimized: Portugal, Spain, Cyprus, Thailand).
Regulatory Edge: Portugal NHR + Jersey holding structure optimizes taxes for global investors (0–12.5% effective).
Scalable Model: Flagship Portugal → €2–5B+ portfolio via SPVs per geography/project.
Latest Updates
Forecasted Portfolio Performance: +18% net IRR across core holdings
New Funds:
Maverick Growth Fund I open for new investors.
First close at €5 million
2nd close at €25-50M
Closed fund with 8 + 2 years timeline
- Target IRR: 20-22%.
- Maverick Property Fund I open for new investors.
- First close at €25M
- 2nd close at €100M (with growth to €250-500M)
- Closed fund with 8 + 2 years timeline
- Target IRR: >18%.
Recent Investments
- SHE Health Clinics expansion (women’s health tech)
- Dr. Health Hotels (Five star health & longevity hotels and resorts)
- Conscious Pharmacist (psychedelic therapies)
- Rock+ (sports nutrition)
- The Savannahs (longevity & assisted lifestyle village development).
Read also: Investment Approach
Current Opportunities
Qualified investors may access:
| Fund / Vehicle | Stage | Focus | Minimum Commitment | Status |
|---|---|---|---|---|
| MGP Growth Fund I | Series B/C | Healthcare & Longevity | €500K | Forming (Q1 2026) |
| Opportunity Co-Invests | Selective | High-conviction deals | €500K | Ongoing |
| Secondaries Portfolio | Mature assets | Portfolio optimization | €2M | Open |
Compliance
Access MGP Investor Portal
[Secure Login] (for existing LPs and approved prospects)
View detailed PPMs, financial reports, portfolio updates.
Track NAV, distributions, and performance metrics.
Submit capital calls and manage commitments.
- Receive invitations for events, webinars, company visits and property site visits.
New investors: Complete our Investor Qualification Form for access consideration.
Key Documents
Available upon request:
- Maverick Growth Fund I teaser
- Maverick Property Fund I teaser
- Portfolio Overview (Q1 2026)
- AML/KYC Requirements
Contact Investor Relations
Email: ir@themaverickgrowthpartners.com
Portal Support: support@themaverickgrowthpartners.com
Qualified Investor Criteria:
Institutional investors, family offices, HNWI with €5M+ liquid assets
Professional clients under MiFID II / Jersey regulations
Existing relationships preferred.
All information is confidential and subject to our Privacy Policy, Terms of Service, and Disclaimer.
This page does not constitute an offer or solicitation.